Earnings Call · Q2 FY2024·2024-08-01

Q2 24EPS +10.53%·Rev n/aQ1 24EPS 0.00%·Rev n/aQ4 23EPS +13.04%·Rev n/aQ3 23EPS +4.55%·Rev n/a⚠ consensus missing

LEXICON PHARMACEUTICALS, INC. LXRX

Lisa DeFrancesco — Host or Investor Relations

Mike Exton — Chief Executive Officer and Director

Jeff Wade — President and Chief Financial Officer

−16.1%1d on move date−14.2% vs SPY3d−18.8%5d−16.8%

Research tier

Behavioral profile computed for 3 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more LXRX calls or request research access.

More LXRX calls Browse calls Request research access